Illumina Ventures Closes Second Fund

September 20, 2021Client News

Gunderson Dettmer represented client Illumina Ventures, an independently managed, healthcare-focused venture firm, in the formation of its $325 million second fund, Illumina Innovation Fund II, L.P.

In the announcement of the fund, founder partner at Illumina Ventures Nick Naclerio said, “Genomics and precision medicine are revolutionizing the healthcare industry. This larger fund enables us to pursue more ambitious projects in the US and Europe while building upon the strategies and core values that have been successful in the past."

The Gunderson deal team included Jaime Narayan, Steve Franklin, Jason Ford, Olga Zolotnik, Samantha Herschmann, and Amanda Chan.

Illumina Ventures